Cargando…

Serotonin (5-HT(3)) receptor antagonists for the reduction of symptoms of low anterior resection syndrome

PURPOSE: Serotonin (5-hydroxytryptamine [5-HT])(3) receptor antagonists are effective for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D), in which exaggerated intestinal/colonic hypermotility is often observed. Recent studies have suggested that the motility disorder, especia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itagaki, Ryohei, Koda, Keiji, Yamazaki, Masato, Shuto, Kiyohiko, Kosugi, Chihiro, Hirano, Atsushi, Arimitsu, Hidehito, Shiragami, Risa, Yoshimura, Yukino, Suzuki, Masato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956481/ https://www.ncbi.nlm.nih.gov/pubmed/24648748 http://dx.doi.org/10.2147/CEG.S55410

Ejemplares similares

Early anal gland adenocarcinoma with a characteristic submucosal tumor-like appearance: a case report
por: Mori, Mikito, et al.
Publicado: (2018)

Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor with complete situs inversus: report of a case
por: Mori, Mikito, et al.
Publicado: (2015)

Management of complicated diverticulitis of the colon
por: Tochigi, Toru, et al.
Publicado: (2017)

Laparoscopic surgery for an esophageal duplication cyst using a near‐infrared indocyanine green fluorescence system: A case report
por: Mori, Mikito, et al.
Publicado: (2019)

Successful hepatic resection for invasive Klebsiella pneumoniae large multiloculated liver abscesses with percutaneous drainage failure: A case report
por: Nojima, Hiroyuki, et al.
Publicado: (2023)

Intra-abdominal ectopic bronchogenic cyst with a mucinous neoplasm harboring a GNAS mutation: A case report
por: Murakami, Takashi, et al.
Publicado: (2022)

An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer
por: Mori, Mikito, et al.
Publicado: (2018)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

Hepatic blood flow by perfusion computed tomography as an imaging biomarker for patients with gastric cancer
por: Shuto, Kiyohiko, et al.
Publicado: (2019)

Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
por: Murao, Satoshi, et al.
Publicado: (2010)

Reduction of the serotonin 5-HT(1B) and 5-HT(2A) receptor-mediated contraction of human pulmonary artery by the combined 5-HT(1B) receptor antagonist and serotonin transporter inhibitor LY393558
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor
por: Mancia, Filippo, et al.
Publicado: (2008)

The Antidepressant 5-HT(2A) Receptor Antagonists Pizotifen and Cyproheptadine Inhibit Serotonin-Enhanced Platelet Function
por: Lin, Olivia A., et al.
Publicado: (2014)

Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects
por: Li, Xiaojiao, et al.
Publicado: (2021)

Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease
por: Neumann, Joachim, et al.
Publicado: (2023)

Can 5-HT(3) Antagonists Really Contribute to Serotonin Toxicity? A Call for Clarity and Pharmacological Law and Order
por: Rojas-Fernandez, Carlos H.
Publicado: (2014)

Concise and Scalable Radiosynthesis of (+)-[(18)F]MDL100907 as a Serotonin 5-HT(2A) Receptor Antagonist for PET
por: Chavan, Lahu N., et al.
Publicado: (2023)

Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT(3A) and 5-HT(6) receptor subtypes
por: Vitalis, Tania, et al.
Publicado: (2013)

Comparative safety of serotonin (5-HT(3)) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2015)

Comparative efficacy of serotonin (5-HT(3)) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis
por: Tricco, Andrea C., et al.
Publicado: (2015)

A new serotonin 5-HT(6) receptor antagonist with procognitive activity – Importance of a halogen bond interaction to stabilize the binding
por: González-Vera, Juan A., et al.
Publicado: (2017)

Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
por: Ostrowska, Kinga, et al.
Publicado: (2021)

Computational approaches for the design of novel dopamine D(2) and serotonin 5-HT(2A) receptor dual antagonist towards schizophrenia
por: Rathore, Akash, et al.
Publicado: (2022)

Biophysical validation of serotonin 5-HT(2A) and 5-HT(2C) receptor interaction
por: Felsing, Daniel E., et al.
Publicado: (2018)

Conservation of 5-HT(1A) receptor-mediated autoinhibition of serotonin (5-HT) neurons in mice with altered 5-HT homeostasis
por: Araragi, Naozumi, et al.
Publicado: (2013)

Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2013)

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review
por: Tricco, Andrea C, et al.
Publicado: (2015)

Marmoset Serotonin 5-HT(1A) Receptor Mapping with a Biased Agonist PET Probe (18)F-F13714: Comparison with an Antagonist Tracer (18)F-MPPF in Awake and Anesthetized States
por: Yokoyama, Chihiro, et al.
Publicado: (2016)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors
por: Lochner, Martin, et al.
Publicado: (2016)

Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose
por: Little, Kimberly, et al.
Publicado: (2018)

The serotonin 5-HT3 receptor: a novel neurodevelopmental target
por: Engel, Mareen, et al.
Publicado: (2013)

The role of serotonin 5-HT(2A) receptors in memory and cognition
por: Zhang, Gongliang, et al.
Publicado: (2015)

Allosteric Inhibition of Serotonin 5-HT(7) Receptors by Zinc Ions
por: Satała, Grzegorz, et al.
Publicado: (2017)

Alterations of Expression of the Serotonin 5-HT4 Receptor in Brain Disorders
por: Rebholz, Heike, et al.
Publicado: (2018)

Mechanistic Studies on the Stereoselectivity of the Serotonin 5‐HT(1A) Receptor
por: Yuan, Shuguang, et al.
Publicado: (2016)

Comparative analysis of palmitoylation sites of serotonin (5‐HT) receptors in vertebrates
por: Kaizuka, Toshie, et al.
Publicado: (2018)

New Triazine Derivatives as Serotonin 5-HT(6) Receptor Ligands
por: Łażewska, Dorota, et al.
Publicado: (2023)

Regulatory mechanism of CCN2 production by serotonin (5-HT) via 5-HT(2A) and 5-HT(2B) receptors in chondrocytes
por: Hori, Ayaka, et al.
Publicado: (2017)

Behavioral Effects of Systemic, Infralimbic and Prelimbic Injections of a Serotonin 5-HT(2A) Antagonist in Carioca High- and Low-Conditioned Freezing Rats
por: León, Laura A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2s4kj96dluvhn5fnl2p3hgf15g